# Observational dyslipidemias studies recruiting: 33 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 33 trials that are observational for dyslipidemias that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational dyslipidemias studies: 33 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/dyslipidemias

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 33
- Recruiting or not yet: 33
- Read on: November 19, 2026

## Trials

The 25 newest of 33, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 13, 2026 | NCT07935187 | Cardiopulmonary Exercise Active Health Cohort Study | Peking University Third Hospital | Observational | Recruiting | Hypertension, Dyslipidemia, Type 2 Diabetes Mellitus (T2DM), Coronary Artery Disease (CAD) (E.G., Angina, Myocardial... | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935187) |
| November 12, 2026 | NCT07930975 | Lipid Management Gaps in Mexican Patients at High and Very High Cardiovascular Risk | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Observational | Not yet recruiting | Dyslipidemias, Hypercholesterolemia, Cardiovascular Diseases | 1,600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930975) |
| November 9, 2026 | NCT07924345 | Observational Study to Evaluate Achieving LDL-cholesterol Target Level to Treat With Rovazet Tab. With Dyslipidemia Patients | HK inno.N Corporation | Observational | Recruiting | Dyslipidemia | 6,713 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924345) |
| November 4, 2026 | NCT07917364 | Asprosin and miRNA Expression in Young Women With Metabolic Syndrome | University of Applied Sciences in Nowy Targ | Observational | Recruiting | Metabolic Syndrome, Insulin Resistance, Obesity, Abdominal, Dyslipidemias | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917364) |
| October 21, 2026 | NCT07884903 | Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks | Shanxi Bethune Hospital | Observational | Not yet recruiting | Obesity & Overweight, Diabetes Mellitus, Type 2, Hypertension, Non-alcoholic Fatty Liver Disease (MASLD)... | 25,974 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07884903) |
| October 19, 2026 | NCT07880717 | Prevalence and Associated Factors of High BMI and Periodontitis in Thai Adults Aged Under 60 Years | Mahidol University | Observational | Recruiting | Diabete Mellitus, Dyslipidaemia, Chronic Kidney Disease, Psychiatric Disorder, Hypertension, Hypothyroidism, Smoking... | 93 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880717) |
| September 22, 2026 | NCT07835282 | Germany on Target Registry | Sponsor not shown (see the record) | Observational | Not yet recruiting | Myocardial Infarction (MI), Dyslipidemias | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07835282) |
| July 27, 2026 | NCT07729553 | Vitamin D Status and Lipid Profile in Obese Adults With Type 2 Diabetes | Sinai University | Observational | Not yet recruiting | Type 2 Diabetes Mellitus, Obesity, Dyslipidemia, Vitamin D Deficiency | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07729553) |
| April 13, 2026 | NCT07523971 | Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study | JW Pharmaceutical | Observational | Recruiting | Dyslipidemias | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07523971) |
| April 7, 2026 | NCT07515560 | Efficacy and Safety of Baroezet Tablet in Korean Patients With Dyslipidemia: A Prospective Observational Study | Daewoong Pharmaceutical Co. LTD. | Observational | Not yet recruiting | Dyslipidemia | 12,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07515560) |
| March 31, 2026 | NCT07502703 | Validation of Remote Photoplethysmography (rPPG)-Derived Cardiovascular Parameters Against Standard Clinical Measurements and Risk Scores... | Tarumanagara University | Observational | Not yet recruiting | Dyslipidemia, Angina (Stable), Coronary Artery Disease (CAD), Heart Disease, Hypertension, Diabetes (DM) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07502703) |
| March 17, 2026 | NCT07476248 | The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association... | Assiut University | Observational | Not yet recruiting | Diabetic Nephropathy, Dyslipidemia | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07476248) |
| March 16, 2026 | NCT07474233 | Associations Between Dietary Patterns, LDL Aggregation, and Cardiometabolic Health | Liverpool John Moores University | Observational | Not yet recruiting | Atherosclerosis Cardiovascular Disease, Metabolic Syndrome, Dyslipidaemia, Endothelial Dysfunction | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07474233) |
| March 12, 2026 | NCT07468500 | Real World Adherence of PCSK9 Targeted Therapy | Novartis Pharmaceuticals | Observational | Not yet recruiting | Dyslipidemia, Hypercholesterolemia | 3,600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07468500) |
| February 17, 2026 | NCT07412457 | Guideline Adherence in Dyslipidemia With Clinical Decision Support | I.M. Sechenov First Moscow State Medical University | Observational | Not yet recruiting | Dyslipidemia, Coronary Artery Disease, Atherosclerosis of Major Arteries, Cardiovascular Risk, Subclinical... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07412457) |
| December 29, 2025 | NCT07308314 | Taining Golden Lake Comprehensive Chronic Disease Management Initiative | First Affiliated Hospital of Fujian Medical University | Observational | Recruiting | Chronic Disease, Chronic Disease Management, Hypertension, Diabetes Mellitus, Dyslipidemias, Frailty, Sarcopenia | 20,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07308314) |
| October 6, 2025 | NCT07208331 | Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Observational | Recruiting | Atherosclerotic Cardiovascular Disease (ASCVD), Hypertension, Dyslipidemia | 750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07208331) |
| October 3, 2025 | NCT07206875 | Observational Study for the Characterisation of Patients Affected by Any Type of Diabetes and Endocrine Disorders | IRCCS San Raffaele | Observational | Recruiting | Diabetes, Metabolic Disorders, Arterial Hypertension, Dyslipidemia, Liver Disease (Alcoholic or Not) | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07206875) |
| July 24, 2025 | NCT07083206 | A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe | Ahn-Gook Pharmaceuticals Co.,Ltd | Observational | Recruiting | Hypercholesterolemia, Dyslipidemias | 4,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07083206) |
| June 29, 2025 | NCT07043166 | Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens | Shanghai Changzheng Hospital | Observational | Recruiting | Metabolic Syndrome, Diabetes, Obesity and Overweight, Hypertension, Dyslipidemia, Thyroid Diseases, Bone Metabolism... | 4,094 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07043166) |
| February 7, 2025 | NCT06814314 | AP Metabolism Transcriptomics | IRCCS Eugenio Medea | Observational | Recruiting | Neurodevelopmental Disorders, Irritability | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06814314) |
| November 19, 2024 | NCT06694012 | Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2 | Osaka Metropolitan University | Observational | Recruiting | Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes, Diabetes Mellitus, Hypertension, Hyperglycemia, Hyperlipidemia... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06694012) |
| November 6, 2024 | NCT06676046 | Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions | National Heart, Lung, and Blood Institute (NHLBI) | Observational | Recruiting | Dyslipidemia, Atherosclerosis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06676046) |
| July 5, 2024 | NCT06486857 | Accuracy Assessment of a Novel Gas Detection Approach in Dyslipidemia Diagnosis | Beijing Anzhen Hospital | Observational | Not yet recruiting | Dyslipidemias, Gas Detection Method | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06486857) |
| May 31, 2023 | NCT05881447 | Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa | Swiss Tropical & Public Health Institute | Observational | Recruiting | Chronic Kidney Diseases, Type 2 Diabetes Mellitus, Arterial Hypertension, Obesity, Cardiovascular Diseases, HIV... | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05881447) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Ahn-Gook Pharmaceuticals Co.,Ltd](https://specstream.ai/data/clinical-trials/company/ahn-gook-pharmaceuticals-co-ltd) | 1 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 1 |
| [JW Pharmaceutical](https://specstream.ai/data/clinical-trials/company/jw-pharmaceutical) | 1 |
| Shanxi Bethune Hospital | 1 |
| Assiut University | 1 |
| IRCCS San Raffaele | 1 |
| Beijing Anzhen Hospital | 1 |
| Mahidol University | 1 |
| Tarumanagara University | 1 |
| Newcastle University | 1 |
| IRCCS Eugenio Medea | 1 |
| I.M. Sechenov First Moscow State Medical University | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| [Daewoong Pharmaceutical Co. LTD.](https://specstream.ai/data/clinical-trials/company/daewoong-pharmaceutical-co-ltd) | 1 |
| Shanghai Changzheng Hospital | 1 |
| Swiss Tropical & Public Health Institute | 1 |
| Sinai University | 1 |
| Harvard School of Public Health (HSPH) | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Beijing Tongren Hospital | 1 |
| Vanderbilt University Medical Center | 1 |
| [HK inno.N Corporation](https://specstream.ai/data/clinical-trials/company/hk-inno-n-corporation) | 1 |
| Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 1 |
| University of Applied Sciences in Nowy Targ | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 6 |
| South Korea | 4 |
| Italy | 3 |
| France | 3 |
| Germany | 2 |
| Netherlands | 2 |
| United Kingdom | 2 |
| United States | 2 |
| Poland | 2 |
| Thailand | 1 |
| Indonesia | 1 |
| Belgium | 1 |
| Finland | 1 |
| Greece | 1 |
| Portugal | 1 |
| Spain | 1 |
| Sweden | 1 |
| Switzerland | 1 |
| Russia | 1 |
| Tanzania | 1 |
| Puerto Rico | 1 |
| Mexico | 1 |
| Japan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Tobacco companies in the United States](https://specstream.ai/data/businesses/tobacco-companies/united-states)
- [Bangladeshi restaurants in the United States](https://specstream.ai/data/businesses/bangladeshi-restaurants/united-states)
- [Education services in the United States](https://specstream.ai/data/businesses/education-services/united-states)
- [Internal medicine practices in the United States](https://specstream.ai/data/businesses/internal-medicine-practices/united-states)
- [Physical therapy clinics in the United States](https://specstream.ai/data/businesses/physical-therapy-clinics/united-states)
- [Tools wholesalers in the United States](https://specstream.ai/data/businesses/tools-wholesalers/united-states)
